In 2014, can we do better than CA125 in the early detection of ovarian cancer?

doi:10.4331/wjbc.v5.i3.286

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10918)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

555

WORD

391

HTML

7050

Figures (1-1)

442

Tables (1-3)

244

Sum=8682

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1291

Download

945

Sum=2236

Aug 26, 2014 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (50)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Biol Chem. Aug 26, 2014; 5(3): 286-300
Published online Aug 26, 2014. doi: 10.4331/wjbc.v5.i3.286

Open in New Tab Full Size Figure Download Figure

Figure 1 Biomarker candidates must be tested in patient samples collected prior to the onset of physical symptoms in ovarian cancer screening strategies.

Citation: Cohen JG, White M, Cruz A, Farias-Eisner R. In 2014, can we do better than CA125 in the early detection of ovarian cancer? World J Biol Chem 2014; 5(3): 286-300
URL: https://www.wjgnet.com/1949-8454/full/v5/i3/286.htm
DOI: https://dx.doi.org/10.4331/wjbc.v5.i3.286